Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $12.70M in the quarter ending June 30, 2025, with 145.35% growth. This brings the company's revenue in the last twelve months to $14.70M, up 5.72% year-over-year. In the year 2024, Verrica Pharmaceuticals had annual revenue of $7.57M with 47.66% growth.

• Revenue (ttm): $14.70M
• Revenue Growth: +5.72%
• P/S Ratio: 3.40
• Revenue / Employee: $207,099
• Employees: 71
• Market Cap: 60.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.57M	2.44M	47.66%
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.